SEC Form D filing
InverseBio Inc., 2026-04-16
An SEC Form D private-offering notice from Cambridge, MA, a $600,000 filer-stated offering target in Biotech. Filed 2026-04-16. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
InverseBio Inc. Verified via SEC Form D
Filed 2026-04-16Filed to raise $600,000First money in 2026-04-01Raised so far $500,000HQ (as filed) Cambridge, MASector Biotech web-verified against the company’s own siteStage (inferred) Pre-seedCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 1 executive & director
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- ColdSnap, Corp., 2026-04-17, $27.3M, Billerica, MA
- KIORA PHARMACEUTICALS INC, 2026-04-21, $5M, Encinitas, CA
- HyperLight Corp, 2026-04-17, $65M, Cambridge, MA
- Aethl Bio, Inc., 2026-04-17, $5M, Pittsburgh, PA
- Nexamp, Inc., 2026-04-17, $180M, Boston, MA
- Bonum Therapeutics, Inc., 2026-04-17, $32.3M, Seattle, WA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.